Truepoint Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Buy |
1,682
+16
| +1% | +$2.97K | 0.01% | 117 |
|
|
2025
Q1 | $349K | Sell |
1,666
-223
| -12% | -$46.7K | 0.01% | 109 |
|
|
2024
Q4 | $336K | Sell |
1,889
-367
| -16% | -$65.2K | 0.01% | 104 |
|
|
2024
Q3 | $446K | Buy |
2,256
+573
| +34% | +$113K | 0.01% | 97 |
|
|
2024
Q2 | $289K | Sell |
1,683
-68
| -4% | -$11.7K | 0.01% | 105 |
|
|
2024
Q1 | $319K | Sell |
1,751
-3,547
| -67% | -$646K | 0.01% | 104 |
|
|
2023
Q4 | $821K | Sell |
5,298
-811
| -13% | -$126K | 0.02% | 92 |
|
|
2023
Q3 | $911K | Buy |
6,109
+3,382
| +124% | +$504K | 0.03% | 82 |
|
|
2023
Q2 | $367K | Buy |
2,727
+938
| +52% | +$126K | 0.01% | 116 |
|
|
2023
Q1 | $285K | Buy |
1,789
+407
| +29% | +$64.9K | 0.01% | 119 |
|
|
2022
Q4 | $223K | Sell |
1,382
-1,017
| -42% | -$164K | 0.01% | 146 |
|
|
2022
Q3 | $322K | Hold |
2,399
| – | – | 0.02% | 115 |
|
|
2022
Q2 | $367K | Buy |
2,399
+1,000
| +71% | +$153K | 0.02% | 119 |
|
|
2022
Q1 | $227K | Buy |
+1,399
| New | +$227K | 0.01% | 130 |
|
|
2021
Q4 | – | Sell |
-6,499
| Closed | -$701K | – | 136 |
|
|
2021
Q3 | $701K | Buy |
6,499
+4,714
| +264% | +$508K | 0.04% | 68 |
|
|
2021
Q2 | $201K | Buy |
+1,785
| New | +$201K | 0.01% | 118 |
|
|
2020
Q1 | – | Sell |
-2,428
| Closed | -$215K | – | 48 |
|
|
2019
Q4 | $215K | Buy |
+2,428
| New | +$215K | 0.02% | 112 |
|
|
2019
Q2 | – | Sell |
-2,496
| Closed | -$201K | – | 122 |
|
|
2019
Q1 | $201K | Buy |
+2,496
| New | +$201K | 0.02% | 107 |
|